1. Skip to Menu
  2. Skip to Content
  3. Skip to Footer>

Act-T4 Cell™ kit

The Act-T4 Cell™ kit is intended to determine the CD4+ T-cell mediated immune response. This antibody combination allows the identification and quantification of effector CD4+ T-cells after incubation of a whole blood sample with mitogens and/or antigens of interest. The increase of activated CD4+ T-cells total percentage is related to the immune response against the stimulus used.

 

This method can be used when studying T cell-mediated immune response against pathogens, auto-antigens and allergens. Moreover, it contributes to the evaluation of a patient's immunocompetence status.

 

Several studies have recently validated the pre-clinical use of the Act-T4 Cell™ method to evaluate antigenspecific response against virus such as Cytomegalovirus (CMV), Epstein-Barr virus (EBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV) or bacteria, e.g. Mycobacterium tuberculosis (MTB). Results were consistent with serology tests, cell proliferation studies and other techniques based on IFN-γ production levels, demonstrating the potential of Act-T4 Cell™ to be an accurate, easy and cost-effective method.

 

Description
Size
Catalog code
Status
TDS
Act-T4 Cell™ kit
100 tests
CYT-AT4C
RUO
PDF
Act-T4 Cell™ kit
Protected by patent
Act-T4 Cell™ kit
Act-T4 Cell™ kit

CD25+ CD134+ CD4+ T-cells in response to mitogens and antigens. a, Dot-plots from a representative healthy adult control showing expression for CD25+ CD134+ CD4+ T-cells in the control culture (0) compared with staining in response to PHA and SEB. b, Representative dot-plots from healthy adult controls showing expression for CD25+ CD134+ CD4+T cells in response to MTB, CMV, and Candida.
The percentage of CD25+ CD134+ CD4+ T-cells is shown for each dot-plot. The gates for CD25+ CD134+ CD4+ T-cells were based on comparison of negative control (no antigen) and positive control (PHA).

 

effector

We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of the site have already been set. To find out more about the cookies we use and how to delete them, see our privacy policy.

I accept cookies from this site.

EU Cookie Directive Module Information